-
1
-
-
0033650534
-
Autologous hematopoietic cell transplantation in Hodgkin's disease
-
Johnston, L. J. and Horning, S. J. (2000) Autologous hematopoietic cell transplantation in Hodgkin's disease. Biol Blood Marrow Transplant, 6, pp. 289-300.
-
(2000)
Biol Blood Marrow Transplant
, vol.6
, pp. 289-300
-
-
Johnston, L.J.1
Horning, S.J.2
-
2
-
-
0038182732
-
High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: A multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence
-
Tarella, C., Cuttica, A., Vitolo, U., Liberati, M., Nicola, M Di and Cortelazzo, S. (2003) High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: A multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence. Cancer, 97, pp. 2748-2759.
-
(2003)
Cancer
, vol.97
, pp. 2748-2759
-
-
Tarella, C.1
Cuttica, A.2
Vitolo, U.3
Liberati, M.4
Nicola, M.5
Di Cortelazzo, S.6
-
3
-
-
0027404777
-
Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNLI randomised trial
-
Linch, D. C., Winfield, D., Goldstone, A. H., Moir, D., Hancock, B. and McMillan, A. (1993) Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNLI randomised trial. Lancet, 341, pp. 1051-1054.
-
(1993)
Lancet
, vol.341
, pp. 1051-1054
-
-
Linch, D.C.1
Winfield, D.2
Goldstone, A.H.3
Moir, D.4
Hancock, B.5
McMillan, A.6
-
4
-
-
0037097044
-
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: A randomised trial
-
Schmitz, N., Pfistner, B., Sextro, M., Sieber, M., Carella, A. M. and Haenel, M. (2002) Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: A randomised trial. Lancet, 359, pp. 2065-2071.
-
(2002)
Lancet
, vol.359
, pp. 2065-2071
-
-
Schmitz, N.1
Pfistner, B.2
Sextro, M.3
Sieber, M.4
Carella, A.M.5
Haenel, M.6
-
5
-
-
0026788310
-
Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: Clinical course and patient follow-up
-
Vose, J. M., Bierman, P. J., Anderson, J. R., Kessinger, A., Pierson, J. and Nelson, J. (1992) Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: Clinical course and patient follow-up. Blood, 80, pp. 2142-2148.
-
(1992)
Blood
, vol.80
, pp. 2142-2148
-
-
Vose, J.M.1
Bierman, P.J.2
Anderson, J.R.3
Kessinger, A.4
Pierson, J.5
Nelson, J.6
-
6
-
-
0033745817
-
Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: A two centre study
-
Shamash, J., Lee, S. M., Radford, J. A., Rohatiner, A. Z., Chang, J. and Morgenstern, G. R. (2000) Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: A two centre study. Ann Oncol, 11, pp. 715-719.
-
(2000)
Ann Oncol
, vol.11
, pp. 715-719
-
-
Shamash, J.1
Lee, S.M.2
Radford, J.A.3
Rohatiner, A.Z.4
Chang, J.5
Morgenstern, G.R.6
-
7
-
-
0033932803
-
Gemcitabine in the treatment of refractory Hodgkin's disease: Results of a multicenter phase II study
-
Santoro, A., Bredenfeld, H., Devizzi, L., Tesch, H., Bonfante, V. and Viviani, S. (2000) Gemcitabine in the treatment of refractory Hodgkin's disease: Results of a multicenter phase II study. J Clin Oncol, 18, pp. 2615-2619.
-
(2000)
J Clin Oncol
, vol.18
, pp. 2615-2619
-
-
Santoro, A.1
Bredenfeld, H.2
Devizzi, L.3
Tesch, H.4
Bonfante, V.5
Viviani, S.6
-
8
-
-
0027483826
-
Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: The 21-year Seattle experience
-
Anderson, J. E., Litzow, M. R., Appelbaum, F. R., Schoch, G., Fisher, L. D. and Buckner, C. D. (1993) Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: The 21-year Seattle experience. J Clin Oncol, 11, pp. 2342-2350.
-
(1993)
J Clin Oncol
, vol.11
, pp. 2342-2350
-
-
Anderson, J.E.1
Litzow, M.R.2
Appelbaum, F.R.3
Schoch, G.4
Fisher, L.D.5
Buckner, C.D.6
-
9
-
-
9044237273
-
Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease
-
Gajewski, J. L., Phillips, G. L., Sobocinski, K. A., Armitage, J. O., Gale, R. P. and Champlin, R. E. (1996) Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease. J Clin Oncol, 14, pp. 572-578.
-
(1996)
J Clin Oncol
, vol.14
, pp. 572-578
-
-
Gajewski, J.L.1
Phillips, G.L.2
Sobocinski, K.A.3
Armitage, J.O.4
Gale, R.P.5
Champlin, R.E.6
-
10
-
-
0030008082
-
Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease
-
Milpied, N., Fielding, A. K., Pearce, R. M., Ernst, P. and Goldstone, A. H. (1996) Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation. J Clin Oncol, 14, pp. 1291-1296.
-
(1996)
J Clin Oncol
, vol.14
, pp. 1291-1296
-
-
Milpied, N.1
Fielding, A.K.2
Pearce, R.M.3
Ernst, P.4
Goldstone, A.H.5
-
11
-
-
20444410110
-
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation
-
Peggs, K. S., Hunter, A., Chopra, R., Parker, A., Mahendra, P. and Milligan, D. (2005) Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation. Lancet, 365, pp. 1934-1941.
-
(2005)
Lancet
, vol.365
, pp. 1934-1941
-
-
Peggs, K.S.1
Hunter, A.2
Chopra, R.3
Parker, A.4
Mahendra, P.5
Milligan, D.6
-
12
-
-
0027770691
-
Second autologous bone marrow transplantation in Hodgkin's disease
-
Avalos, B. R. and Copelan, E. A. (1993) Second autologous bone marrow transplantation in Hodgkin's disease. Bone Marrow Transplant, 12, pp. 665-667.
-
(1993)
Bone Marrow Transplant
, vol.12
, pp. 665-667
-
-
Avalos, B.R.1
Copelan, E.A.2
-
13
-
-
0036269422
-
Second autologous stem cell transplant for multiply relapsed Hodgkin's disease
-
Lin, T. S., Avalos, B. R., Penza, S. L., Marcucci, G., Elder, P. J. and Copelan, E. A. (2002) Second autologous stem cell transplant for multiply relapsed Hodgkin's disease. Bone Marrow Transplant, 29, pp. 763-767.
-
(2002)
Bone Marrow Transplant
, vol.29
, pp. 763-767
-
-
Lin, T.S.1
Avalos, B.R.2
Penza, S.L.3
Marcucci, G.4
Elder, P.J.5
Copelan, E.A.6
-
14
-
-
0030949743
-
Role of a second transplant in the management of poor-prognosis lymphomas: A report from the European Blood and Bone Marrow Registry
-
Vandenberghe, E., Pearce, R., Taghipour, G., Fouillard, L. and Goldstone, A. H. (1997) Role of a second transplant in the management of poor-prognosis lymphomas: A report from the European Blood and Bone Marrow Registry. J Clin Oncol, 15, pp. 1595-1600.
-
(1997)
J Clin Oncol
, vol.15
, pp. 1595-1600
-
-
Vandenberghe, E.1
Pearce, R.2
Taghipour, G.3
Fouillard, L.4
Goldstone, A.H.5
-
15
-
-
0036467658
-
Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: Mature results of a prospective clinical trial
-
Horning, S. J., Hoppe, R. T., Breslin, S., Bartlett, N. L., Brown, B. W. and Rosenberg, S. A. (2002) Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: Mature results of a prospective clinical trial. J Clin Oncol, 20, pp. 630-637.
-
(2002)
J Clin Oncol
, vol.20
, pp. 630-637
-
-
Horning, S.J.1
Hoppe, R.T.2
Breslin, S.3
Bartlett, N.L.4
Brown, B.W.5
Rosenberg, S.A.6
-
16
-
-
33751531237
-
Could BEACOPP be the new standard for the treatment of advanced Hodgkin's lymphoma (HL)?
-
Diehl, V. and Behringer, K. (2000) Could BEACOPP be the new standard for the treatment of advanced Hodgkin's lymphoma (HL)?. Cancer Invest, 24, pp. 713-717.
-
(2000)
Cancer Invest
, vol.24
, pp. 713-717
-
-
Diehl, V.1
Behringer, K.2
|